Organization
Shengjing Hospital of China Medical University
5 abstracts
Abstract
Reflections on the changes in ascites and serum VEGF1 levels before and after intraperitoneal infusion of bevacizumab.Org: Shengjing Hospital Affiliated to China Medical University, Shengjing Hospital of China Medical University,
Abstract
Early-stage lung adenocarcinoma with a micropapillary pattern showing a distinct immunogenic tumor microenvironment.Org: Shengjing Hospital of China Medical University, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, China,
Abstract
Differences of prediction performances by multigene assays in patients with breast cancer with distinct genetic backgrounds.Org: Shengjing Hospital of China Medical University, Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd, The Medical Department, Nanjing Simcere Medical Laboratory Science Co., Ltd,
Abstract
Neoadjuvant tucidinostat combined with chemotherapy for hormone receptor-positive, HER2-negative breast cancer.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Shengjing Hospital of China Medical University, Department of Breast Surgery, Kyorin University School of Medicine/Saitama Medical Center, Tokyo, Japan, The First Affiliated Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China,
Abstract
Tumor immune microenvironment (TIME) analysis of stage I lung adenocarcinoma with micropapillary pattern.Org: Shengjing Hospital of China Medical University, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,